Data as of November 12, 2026

Adderall 30 mg Tablet

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE

Brand: Adderall

Acquisition price (NADAC) is as of October 21, 2026. Medicaid reimbursement figures are from 2024, the most recent year in CMS's published claims data. The two are not contemporaneous — treat any comparison as directional, not exact.

Price per fill

NADAC (acquisition)
$633.07/ fill$12.25 / EA
VA Big4
$359.63/ fill$6.96 / EA
FUL
$22.40/ fill$0.43 / EA
AMP
$12.09/ fill$0.23 / EA
Medicaid FFS
$435.28/ fill
Medicaid MCO
$506.30/ fill

Sources: cms/nadac:price-ladder · va/fss-drug-prices:normalized · cms/ful:generic-ceiling · cms/sdud

What's in the reimbursement

Ingredient cost (51.7 units/fill)$633.07
Dispensing fee & other (state-fixed, not margin)-$197.79
Total reimbursed per fill$435.28

The gap above stays roughly flat across drugs regardless of acquisition cost — that's the professional dispensing fee, a fixed per-fill amount the state pays every pharmacy, not a markup.

Medicaid volume backing this card: 10 fee-for-service states, 17 managed-care states.

Full methodology and source columns: /tools/drug-prices/methodology

Sources: acquisition prices from CMS's National Average Drug Acquisition Cost survey, effective 2026-10-28; utilisation from CMS State Drug Utilization Data, 2024; Cost Plus Drugs prices from their published price list. NADAC and SDUD vintages differ. Every number links to how it was calculated. Full methodology